Human papillomavirus (HPV) prevalence and HPV type distribution in cervical, vulvar, and anal cancers in central and eastern Europe

Acta Dermatovenerologica Alpina, Pannonica et Adriatica

Volumn 22, Issue 1, 2013, Pages 1-5

  Škamperle, Mateja ^a   Kocjan, Boštjan J ^a   Maver, Polona J ^a   Seme, Katja ^a   Poljak, Mario ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

ANUS CANCER; ARTICLE; EUROPE; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; UTERINE CERVIX CANCER; VULVA CANCER; WART VIRUS;

ADULT; AGED; ANUS NEOPLASMS; DNA, VIRAL; EUROPE; EUROPE, EASTERN; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PREVALENCE; UTERINE CERVICAL NEOPLASMS; VULVAR NEOPLASMS;

EID: 84878026482     PISSN: 13184458     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10162-012-0024-1     Document Type: Article

References (34)

1. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, et al. A review of human carcinogens - Part B: biological agents. Lancet Oncol. 2009;10:321-2.
2. Kesic V, Poljak M, Rogovskaya S. Cervical cancer burden and prevention activities in Europe. Cancer Epidemiol Biomarkers Prev. 2012;21:1423-33.
3. Todorova I, Ganchev G, Shikova E. Human papillomavirus prevalence in invasive cervical carcinomas in Bulgaria, J Clin Pathol. 2010;63:1121-3.
4. Dabic MM, Hlupic L, Babic D, Jukic S, Seiwerth S. Comparison of polymerase chain reaction and catalyzed signal amplification in situ hybridization methods for human papillomavirus detection in paraffin-embedded cervical preneoplastic and neoplastic lesions. Arch Med Res. 2004;35:511-6. (Pubitemid 41043622)
5. Hadzisejdic I, Simat M, Bosak A, Krasevic M, Grahovac B. Prevalence of human papillomavirus genotypes in cervical cancer and precursor lesions. Coll Antropol. 2006;30:879-83.
6. Hadzisejdic I, Krasevic M, Haller H, Grahovac B. Distribution of human papillomavirus types in different histological subtypes of cervical adenocarcinoma. Coll Antropol. 2007;31:97-102.
7. Tachezy R, Mikyskova I, Salakova M, Van Ranst M. Correlation between human papillomavirus-associated cervical cancer and P53 codon 72 arginine/proline polymorphism. Hum Genet. 1999;105:564-6. (Pubitemid 30026033)
8. Tachezy R, Hamsikova E, Hajek T, Mikyskova I, Smahel M, Van Ranst M, et al. Human papillomavirus genotype spectrum in Czech women: correlation of HPV DNA presence with antibodies against HPV-16, 18, and 33 virus-like particles. J Med Virol. 1999;58:378-86. (Pubitemid 29326052)
9. Tachezy R, Smahelova J, Salakova M, Arbyn M, Rob L, Skapa P, et al. Human papillomavirus genotype distribution in Czech women and men with diseases etiologically linked to HPV. PLoS One. 2011;6:e21913.
10. Silins I, Wang X, Tadesse A, Jansen KU, Schiller JT, Avall-Lundqvist E, et al. A population-based study of cervical carcinoma and HPV infection in Latvia. Gynecol Oncol. 2004;93:484-92. (Pubitemid 38507623)
11. Gudleviciene Z, Didziapetriene J, Ramael M, Uleckiene S, Valuckas KP. Human papillomavirus and p53 polymorphism in Lithuanian cervical cancer patients. Gynecol Oncol. 2006;102:530-3. (Pubitemid 44353646)
12. Bar JK, Harlozinska A, Sedlaczek P, Kasiak J, Markowska J. Relations between the expression of p53, c-erbB-2, Ki-67 and HPV infection in cervical carcinomas and cervical dysplasias. Anticancer Res. 2001;21:1001-6. (Pubitemid 32494199)
13. Stenzel A, Semczuk A, Rozynskal K, Jakowicki J, Wojcierowski J. "Low-risk" and "high-risk" HPV-infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases. Pathol Res Pract. 2001;197:597-603. (Pubitemid 32834399)
14. Dybikowska A, Licznerski P, Podhajska A. HPV detection in cervical cancer patients in northern Poland. Oncol Rep. 2002;9:871-4.
15. Lukaszuk K, Liss J, Wozniak I, Sliwinski W, Emerich J, Wojcikowski C. HPV and histological status of pelvic lymph node metastases in cervical cancer: a prospective study. J Clin Pathol. 2004;57:472-6. (Pubitemid 38621791)
16. Bardin A, Vaccarella S, Clifford GM, Lissowska J, Rekosz M, Bobkiewicz P, et al. Human papillomavirus infection in women with and without cervical cancer in Warsaw, Poland. Eur J Cancer. 2008;44:557-64.
17. Szostek S, Klimek M, Zawilinska B, Kosz-Vnenchak M. Genotype-specific human papillomavirus detection in cervical smears. Acta Biochim Pol. 2008;55:687-92.
18. Kwasniewska A, Korobowicz E, Zdunek M, Skoczynski M, Kwasniewski W, Danilos J, et al. Prevalence of Chlamydia trachomatis and herpes simplex virus 2 in cervical carcinoma associated with human papillomavirus detected in paraffin-sectioned samples. Eur J Gynaecol Oncol. 2009;30:65-70.
19. Nowakowski A, De Sanjose S, Alemany L, Klaustermeier JE, Lloveras B, Kotarski I, et al. HPV prevalence and genotype distribution in cervical cancer in Poland. In: Epidemiology/public health abstract book. Abstract of the 27th papillomavirus conference and clinical workshop; 2011 Sep 17-22; Berlin. Berlin (Germany); 2011. p. 52.
20. Pavai Z, Fule T, Horvath E, Mathe M, Pap Z, Denes L, et al. Comparative detection of high-risk HPV (16, 18, 33) in cervical bioptic material of county hospital of Tg. Mures. Rom J Morphol Embryol. 2006;47:229-34.
21. Goia-Rusanu CD, Iancu IV, Botezatu A, Socolov D, Huica I, Plesa A, et al. Mitochondrial DNA mutations in patients with HRHPV-related cervical lesions. Roum Arch Microbiol Immunol. 2011;70:5-10.
22. Botezatu A, Goia-Rusanu CD, Iancu IV, Huica I, Plesa A, Socolov D, et al. Quantitative analysis of the relationship between microRNAi24a, -34b and -203 gene methylation and cervical oncogenesis. Mol Med Report, 2011;4:121-8.
23. Iancu IV, Botezatu A, Goia-Rusanu CD, Stanescu A, Huica I, Nistor E, et al. TGF-beta signalling pathway factors in HPV-induced cervical lesions. Roum Arch Microbiol Immunol. 2010;69:113-8.
24. Malisic E, Jankovic R, Jakovljevic K, Cavic M. HPV infection and TP53 codon 72 polymorphism in cervical carcinoma patients from Serbia. In Vivo. 2011;25:541.
25. Ursic-Vrscaj M, Kovacic J, Poljak M, Marin J. Association of risk factors for cervical cancer and human papilloma viruses in invasive cervical cancer. Eur J Gynaecol Oncol. 1996;17:368-71. (Pubitemid 26381523)
26. Jancar N, Kocjan BJ, Poljak M, Lunar MM, Bokal EV. Distribution of human papillomavirus genotypes in women with cervical cancer in Slovenia. Eur J Obstet Gynecol Reprod Biol. 2009;145:184-8.
27. Tachezy R, Jirasek T, Salakova M, Ludvikova V, Kubecova M, Horak L, et al. Human papillomavirus infection and tumours of the anal canal: correlation of histology, PCR detection in paraffin sections and serology. APMIS. 2007;115:195-203. (Pubitemid 46426654)
28. Komlos KF, Kocjan BJ, Kosorok P, Rus T, Toplak J, Bunic M, et al. Distribution of HPV genotypes in Slovenian patients with anal carcinoma: preliminary results. Acta dermatovenerol Alp Panonica Adriat. 2011;20:141-3.
29. Skapa P, Zamecnik J, Hamsikova E, Salakova M, Smahelova J, Jandova K, et al. Human papillomavirus (HPV) profiles of vulvar lesions: possible implications for the classification of vulvar squamous cell carcinoma precursors and for the efficacy of prophylactic HPV vaccination. Am J Surg Pathol. 2007;31:1834-43. (Pubitemid 350175810)
30. Kowalewska M, Szkoda MT, Radziszewski J, Ptaszynski K, Bidzinski M, Siedlecki JA. The frequency of human papillomavirus infection in Polish patients with vulvar squamous cell carcinoma. Int J Gynecol Cancer. 2010;20:434-7.
31. Sahasrabuddhe W, Castle PE, Follansbee S, Borgonovo S, Tokugawa D, Schwartz LM, et al. Human papillomavirus genotype attribution and estimation of preventable fraction of anal intraepithelial neoplasia cases among HIV-infected men who have sex with men. J Infect Dis. 2013;207:392-401.
32. de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11:1048-56.
33. Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication. Int J Cancer. 2011;128:927-35.
34. De Vuyst H, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer. 2009;124:1626-36.